These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 29771383)
21. Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA). Shastri S; Katz R; Shlipak MG; Kestenbaum B; Peralta CA; Kramer H; Jacobs DR; de Boer IH; Cushman M; Siscovick D; Sarnak MJ Am J Kidney Dis; 2011 Jun; 57(6):832-40. PubMed ID: 21296473 [TBL] [Abstract][Full Text] [Related]
22. Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Chonchol M; Gitomer B; Isakova T; Cai X; Salusky I; Pereira R; Abebe K; Torres V; Steinman TI; Grantham JJ; Chapman AB; Schrier RW; Wolf M Clin J Am Soc Nephrol; 2017 Sep; 12(9):1461-1469. PubMed ID: 28705885 [TBL] [Abstract][Full Text] [Related]
23. Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis. Ong KL; McClelland RL; Allison MA; Kokkinos J; Wu BJ; Barter PJ; Rye KA Atherosclerosis; 2019 Feb; 281():200-206. PubMed ID: 30446181 [TBL] [Abstract][Full Text] [Related]
24. Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans. Naik RP; Derebail VK; Grams ME; Franceschini N; Auer PL; Peloso GM; Young BA; Lettre G; Peralta CA; Katz R; Hyacinth HI; Quarells RC; Grove ML; Bick AG; Fontanillas P; Rich SS; Smith JD; Boerwinkle E; Rosamond WD; Ito K; Lanzkron S; Coresh J; Correa A; Sarto GE; Key NS; Jacobs DR; Kathiresan S; Bibbins-Domingo K; Kshirsagar AV; Wilson JG; Reiner AP JAMA; 2014 Nov; 312(20):2115-25. PubMed ID: 25393378 [TBL] [Abstract][Full Text] [Related]
25. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake. Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH; Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935 [TBL] [Abstract][Full Text] [Related]
26. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function. Okubo A; Nakashima A; Doi S; Doi T; Ueno T; Maeda K; Tamura R; Yamane K; Masaki T Clin Exp Nephrol; 2020 May; 24(5):435-443. PubMed ID: 32076888 [TBL] [Abstract][Full Text] [Related]
27. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study. Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427 [TBL] [Abstract][Full Text] [Related]
28. Association of serum fibroblast growth factor 21 with kidney function in a population-based Chinese cohort. Zhang R; Li Y; Zhou X; Zhang F; Li M; Zhang S; Zhang X; Wen X; Ji L Medicine (Baltimore); 2021 Dec; 100(50):e28238. PubMed ID: 34918690 [TBL] [Abstract][Full Text] [Related]
29. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults. Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700 [TBL] [Abstract][Full Text] [Related]
30. Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population. Guessous I; McClellan W; Kleinbaum D; Vaccarino V; Hugues H; Boulat O; Marques-Vidal P; Paccaud F; Theler JM; Gaspoz JM; Burnier M; Waeber G; Vollenweider P; Bochud M Clin J Am Soc Nephrol; 2015 Jul; 10(7):1162-9. PubMed ID: 25901090 [TBL] [Abstract][Full Text] [Related]
31. Collagen biomarkers are associated with decline in renal function independently of blood pressure and other cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis Study. Duprez DA; Gross MD; Ix JH; Peralta CA; Kizer JR; Shea S; Jacobs DR J Hypertens; 2019 Dec; 37(12):2398-2403. PubMed ID: 31356403 [TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor 21 (FGF21) in children and adolescents with chronic kidney disease. Gamrot Z; Adamczyk P; Świętochowska E; Roszkowska-Bjanid D; Gamrot J; Szczepańska M Physiol Res; 2020 Jul; 69(3):451-460. PubMed ID: 32469231 [TBL] [Abstract][Full Text] [Related]
33. A higher ratio of refined grain to whole grain is associated with a greater likelihood of chronic kidney disease: a population-based study. Mazidi M; Katsiki N; Mikhailidis DP; Banach M Br J Nutr; 2019 Jun; 121(11):1294-1302. PubMed ID: 30375292 [TBL] [Abstract][Full Text] [Related]
34. Clinical and biological determinants of kidney outcomes in a population-based cohort study. Guessous I; Ponte B; Marques-Vidal P; Paccaud F; Gaspoz JM; Burnier M; Waeber G; Vollenweider P; Bochud M Kidney Blood Press Res; 2014; 39(1):74-85. PubMed ID: 25011916 [TBL] [Abstract][Full Text] [Related]
35. Fibroblast growth factor-23 and the long-term risk of hospital-associated AKI among community-dwelling older individuals. Brown JR; Katz R; Ix JH; de Boer IH; Siscovick DS; Grams ME; Shlipak M; Sarnak MJ Clin J Am Soc Nephrol; 2014 Feb; 9(2):239-46. PubMed ID: 24262510 [TBL] [Abstract][Full Text] [Related]
36. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Gupta J; Mitra N; Kanetsky PA; Devaney J; Wing MR; Reilly M; Shah VO; Balakrishnan VS; Guzman NJ; Girndt M; Periera BG; Feldman HI; Kusek JW; Joffe MM; Raj DS; Clin J Am Soc Nephrol; 2012 Dec; 7(12):1938-46. PubMed ID: 23024164 [TBL] [Abstract][Full Text] [Related]
37. Thyroid hormones associate with risk of incident chronic kidney disease and rapid decline in renal function: a prospective investigation. Huang X; Ding L; Peng K; Lin L; Wang T; Zhao Z; Xu Y; Lu J; Chen Y; Wang W; Bi Y; Ning G; Xu M J Transl Med; 2016 Dec; 14(1):336. PubMed ID: 27914474 [TBL] [Abstract][Full Text] [Related]
38. Relation Between Calcified Atherosclerosis in the Renal Arteries and Kidney Function (from the Multi-Ethnic Study of Atherosclerosis). Vashishtha D; McClelland RL; Ix JH; Rifkin DE; Jenny N; Allison M Am J Cardiol; 2017 Oct; 120(8):1434-1439. PubMed ID: 28826901 [TBL] [Abstract][Full Text] [Related]
39. Association of Albuminuria With Chronic Kidney Disease Progression in Persons With Chronic Kidney Disease and Normoalbuminuria : A Cohort Study. Verma A; Schmidt IM; Claudel S; Palsson R; Waikar SS; Srivastava A Ann Intern Med; 2024 Apr; 177(4):467-475. PubMed ID: 38560911 [TBL] [Abstract][Full Text] [Related]
40. Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency. Levey AS; Gansevoort RT; Coresh J; Inker LA; Heerspink HL; Grams ME; Greene T; Tighiouart H; Matsushita K; Ballew SH; Sang Y; Vonesh E; Ying J; Manley T; de Zeeuw D; Eckardt KU; Levin A; Perkovic V; Zhang L; Willis K Am J Kidney Dis; 2020 Jan; 75(1):84-104. PubMed ID: 31473020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]